UNIVERSITY OF BIRMINGHAM TO CONDUCT COVID-19 TEST EVALUATION

Self-Testing Evaluation

Birmingham Biotech has partnered with the University of Birmingham to conduct a performance evaluation of its test kits with patients using the device as a self-test.

Performance Evaluation

Birmingham Biotech has partnered with the University of Birmingham to conduct a performance evaluation on its rapid and ELISA antibody tests for the nucleocapsid and spike proteins of the virus. The rapid tests yield a quantitative result while the ELISA tests wield a qualitative result.
The primary objective is to evaluate the performance of the tests in a cohort of patients with naturally gained immunity and vaccine induced immunity.